Westlake Chemical (WLK) Stock Forecast & Price Target

Westlake is supported by a vertically integrated model that links commodity chemicals to higher-margin building products, giving the company a mix of cyclical upside and more stable earnings that the market has not fully reflected in its peer-like valuation. Its HIP segment, which began operating in 2022 and has room for accretive M&A, appears to be a key catalyst, especially with management confident in roughly $600M of y/y EBITDA improvement and RBC estimating 2026E EBITDA of $1.96B. The balance sheet also looks healthy at about 2.5x net leverage, while solid order books, price increases in PE and PVC, and infrastructure-driven demand in pipes, fittings, siding, and trim support a favorable fundamental outlook.

Westlake is facing a weaker fundamental setup as challenging conditions in HIP and softer pricing and margin assumptions in the commodity chemicals business are pressuring earnings. Management’s closure of the Cologne, Germany PVC plant underscores the need to rationalize high-cost capacity, but the expected ~$205M in pre-tax charges and continued regional weakness, elevated energy and logistics costs, and Asian export competition point to persistent operating headwinds. With 3Q earnings expected to decline sequentially and 2026E/27E EBITDA cut to $1,710M/$1,864M from $1,935M/$2,061M, the outlook reflects both cyclical pressure and limited near-term margin recovery.